Kana Hashimoto
Tokyo, 1138677, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Prognostic impact of oligometastasis in older patients with extensive-stage small cell lung cancer.
Journal: Respiratory investigation
Published: January 14, 2025
Prophylactic cranial irradiation for limited-stage small-cell lung cancer in the modern magnetic resonance imaging era may be omitted: a propensity score-matched analysis.
Journal: Journal of radiation research
Published: July 30, 2024
Candidate tumor-specific CD8+ T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis.
Journal: Oncoimmunology
Published: July 02, 2024
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301).
Journal: JTO clinical and research reports
Published: March 07, 2024
Real-world Prognostic Data on Unresectable Stage III Non-small-cell Lung Cancer Treated with Concurrent Chemoradiation Therapy by Histological Type.
Journal: Internal medicine (Tokyo, Japan)
Published: February 12, 2024
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: November 22, 2023
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901).
Journal: Future oncology (London, England)
Published: January 17, 2022
Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy.
Journal: Translational lung cancer research
Published: October 04, 2021
A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients.
Journal: International journal of clinical oncology
Published: October 26, 2020
Development of Hepatocellular Carcinoma During Nivolumab Treatment for Recurrent Non-Small Cell Lung Cancer: A Case Report.
Journal: The Tohoku journal of experimental medicine
Published: April 19, 2019
Correlation between the qualification for bevacizumab use and the survival of patients with non-small cell lung cancer harboring the epidermal growth factor receptor mutation: a retrospective analysis.
Journal: Journal of cancer research and clinical oncology
Published: April 04, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026